title: Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.
abstract: Immunodominance refers to the restricted peptide specificity of T cells that are detectable after an adaptive immune response. For CD4 T cells, many of the mechanisms used to explain this selectivity suggest that events related to Ag processing play a major role in determining a peptide's ability to recruit CD4 T cells. Implicit in these models is the prediction that the molecular context in which an antigenic peptide is contained will impact significantly on its immunodominance. In this study, we present evidence that the selectivity of CD4 T cell responses to peptides contained within protein Ags is not detectably influenced by the location of the peptide in a given protein or the primary sequence of the protein that bears the test peptide. We have used molecular approaches to change the location of peptides within complex protein Ags and to change the flanking sequences that border the peptide epitope to now include a protease site, and find that immunodominance or crypticity of a peptide observed in its native protein context is preserved. Collectively, these results suggest immunodominance of peptides contained in complex Ags is due to an intrinsic factor of the peptide, based upon the affinity of that peptide for MHC class II molecules. These findings are discussed with regard to implications for vaccine design.
authors: David H. Smith Center for Vaccine Biology and Immunology, AaB Institute of Biomedical Sciences, Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.
authors: Jason M
authors: JM
authors: Weaver
authors: Christopher A
authors: CA
authors: Lazarski
authors: Katherine A
authors: KA
authors: Richards
authors: Francisco A
authors: FA
authors: Chaves
authors: Scott A
authors: SA
authors: Jenks
authors: Paula R
authors: PR
authors: Menges
authors: Andrea J
authors: AJ
authors: Sant
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D000939:Epitopes; D000949:Histocompatibility Antigens Class II; D007519:Isoantigens / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D010446:Peptide Fragments / Q000276:immunology; D010455:Peptides / Q000276:immunology*; D011506:Proteins / Q000276:immunology; D037182:T-Cell Antigen Receptor Specificity / Q000276:immunology*; D014612:Vaccines
chemical_list: D000939:Epitopes; D000949:Histocompatibility Antigens Class II; D007519:Isoantigens; D010446:Peptide Fragments; D010455:Peptides; D011506:Proteins; D014612:Vaccines